Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection

Omicron has become the globally dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, creating additional challenges due to its ability to evade neutralization. Here, we report that neutralizing antibodies against Omicron variants are undetected following COVID-19 infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hye Won, Kim, Se-Mi, Jung, Min Kyung, Noh, Ji Yun, Yoo, Ji-Seung, Kim, Eun-Ha, Kim, Young-Il, Yu, Kwangmin, Jang, Seung-Gyu, Gil, Juryeon, Casel, Mark Anthony, Rare, Rollon, Choi, Jeong Ho, Kim, Hee-Sung, Kim, Jun Hyoung, Um, Jihye, Kim, Chaeyoon, Kim, Yeonjae, Chin, Bum Sik, Jung, Sungmin, Choi, Jun Yong, Song, Kyoung-Ho, Kim, Yong-Dae, Park, Jun-Sun, Song, Joon Young, Shin, Eui-Cheol, Choi, Young Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482837/
https://www.ncbi.nlm.nih.gov/pubmed/36182684
http://dx.doi.org/10.1016/j.xcrm.2022.100764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482837/
https://www.ncbi.nlm.nih.gov/pubmed/36182684
http://dx.doi.org/10.1016/j.xcrm.2022.100764

Ejemplares similares